Hoth Therapeutics and Algorithm Sciences Execute Letter of I

/PRNewswire/ -- Hoth Therapeutics, Inc. (NASDAQ: HOTH), a patient focused biopharmaceutical company, today announced it has signed a Letter of Intent to merge...

Related Keywords

Mike Tilton , Robb Knie , Astra Zeneca , Anthony Zook , Hoth Therapeutics Inc , Lr Advisors , Nasdaq , Algorithm Sciences Inc , Exchange Commission , Chief Executive Officer , Pulmonary Arterial Hypertension , Hoth Therapeutics , Algorithm Sciences , David Cavalier , Investigational New Drug , Securities Act , Proposed Transactions , Private Securities Litigation Reform Act , Annual Report , Nc ,